Related Experiment Video
Updated: Sep 27, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia
Christer Lidman1, Lars G Burman, Asa Lagergren
1Division of Infectious Diseases, University Hospital Huddinge, Stockholm, Sweden. Christer.Lidman@medhs.ki.se
Abstract:
Current guidelines recommend microbiological diagnostic procedures as a part of the management of patients hospitalized for community-acquired pneumonia (CAP), but the value of such efforts has been questioned. Patients hospitalized for CAP were studied retrospectively, focusing on the use of aetiological diagnostic methods and their clinical impact. Adult patients, without known human immunodeficiency virus infection, admitted to hospital for CAP during 12 months, were evaluated with regard to the importance of aetiological diagnosis for tailoring antibiotic therapy, antibiotic-associated diarrhoea, Clostridium difficile disease, length of hospital stay and mortality. Of the 605 studied patients, 482 (80%) were subjected to Mycoplasma pneumoniae and/or respiratory virus serology and/or cultures of blood and/or sputum. They had a better prognosis than patients not subjected to microbiological diagnostics (mortality within 3 months was 9% vs 24%, p = 0.001), apparently reflecting differences in general health (e.g. less dementia diagnosis) but not the outcome of diagnostics. A presumptive aetiology was obtained only in 132 of the 482 patients, Streptococcus pneumoniae and M. pneumoniae being the most common agents (in 49 and 36 patients, respectively). Establishing an aetiological diagnosis had no impact on the number of in-hospital changes of therapy, on the proportion of new regimens having a narrower antimicrobial spectrum than the initial one or on the outcome. Therapy was changed to a drug directed specifically against the identified pathogen in only 16 out of these 132 patients and again without any overall improvement in the outcome variables. In a setting with a low frequency of antibiotic-resistant respiratory tract pathogens current routine microbiological diagnostics were found to be of limited value for the clinical management of patients hospitalized for CAP. Improved diagnostics in CAP are urgently needed, as establishing an aetiological diagnosis carries a potential for optimizing the antibiotic therapy.
Insights
Microbiological diagnostics for community-acquired pneumonia (CAP) showed limited clinical impact. Establishing an etiological diagnosis did not improve patient outcomes or antibiotic therapy adjustments in this study.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Pulmonology
Background:
- Current guidelines recommend microbiological diagnostics for community-acquired pneumonia (CAP).
- The clinical utility of these diagnostic efforts in CAP management remains debated.
- Retrospective analysis of etiological diagnostic methods and their impact on patient outcomes is crucial.
Purpose of the Study:
- To evaluate the clinical impact of etiological diagnostic methods in hospitalized patients with CAP.
- To assess the influence of diagnosis on antibiotic therapy tailoring, length of stay, and mortality.
- To determine the value of current microbiological diagnostics in optimizing CAP management.
Main Methods:
- Retrospective study of 605 adult patients hospitalized for CAP.
- Analysis of microbiological diagnostic procedures including serology and cultures.
- Evaluation of clinical outcomes: antibiotic therapy changes, Clostridium difficile disease, length of stay, and mortality.
Main Results:
- 80% of patients underwent microbiological diagnostics; they had a better prognosis but not due to diagnostics.
- Etiological diagnosis was established in only 132 patients, with Streptococcus pneumoniae and Mycoplasma pneumoniae being most common.
- Establishing a diagnosis had no impact on therapy changes, antimicrobial spectrum, or patient outcomes.
Conclusions:
- Routine microbiological diagnostics for CAP have limited value in clinical management, especially with low antibiotic resistance.
- Improved diagnostic methods are urgently needed to optimize antibiotic therapy for CAP patients.
- Etiological diagnosis holds potential for optimizing antibiotic treatment, but current methods are insufficient.
Related Concept Videos
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Automated Microbial Diagnostics
Rapid Identification of Pathogens
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...